Redefining Alopecia Areata Management with Baricitinib Transition from Clinical Trials to RWE in Plaque Psoriasis

المقدمة
سجل الان

Updates about Psoriasis and Alopecia Areata management

الأهداف

Communicate Baricitinib and Ixekizumab value proposition in a speaker program setting to communicate what the product may mean to people living with Alopecia Areata and Psoriasis Diseases

المستهدفين :

Physician ( Dermatology )

Resident / Fellow ( Dermatology )

Pharmacy

المتحدثين

Dr Abdulhadi Jfri

Assistant Professor of Dermatology
Consultant dermatologist, King Abdulaziz Medical City (NGH), Jeddah

Dr. Abdullah Alkhalifa, MD

Adjunct Assistant Professor, College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh, KSA
Consultant dermatologist, Prince Sultan Military Medical City, Riyadh, KSA

Dr. Afaf Abdulaziz Al-Sheikh, MD, FAAD

Consultant Dermatologist
Head division of Dermatology,
Department of Medicine
King Abdulaziz Medical City, Riyadh
Assistant Professor, King Saud Bin
Abdulaziz University for Health
Sciences